As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: July 25, 2014
by Fiona MacRae for IOL Lifestyle:
Around 40 percent of people looking after loved ones with dementia are clinically depressed or suffering from anxiety, it has emerged.
Experts say the “profound effect” that Alzheimer’s has on family members who acts as carers is too often forgotten.
Rebecca Wood, chief executive of the Alzheimer’s Research UK charity, said: “Dementia doesn’t only affect those who are diagnosed with the condition. Its effects are felt far and wide, not least for individuals and families who are caring for their loved ones.”
The hidden toll of dementia was revealed by researchers from University College London who crunched together the results of studies from around the world.
This showed 40 percent of those who look after a family member with dementia to be clinically depressed or suffering from anxiety at any one time.
With two-thirds of people with dementia living at home and 670 000 carers in Britain, this equates to almost 270 000 men and women.
Researcher Professor Gill Livingston, of University College London, said that the care of a relative with dementia can be particularly taxing because of the length of the illness and its nature. Patients often do not realise they are ill and so resist help.
Physical help with nursing and chores is available but does not seem to cut the carer’s odds of mental health problems.
Now Professor Livingston and colleagues at UCL have devised a course designed to help carers.
They put 173 carers through an eight-hour course and compared their progress with 90 who went about their lives as usual.
After two years, those who did the short course were seven times less likely to be depressed than the others, the Alzheimer’s Association International Conference in Copenhagen heard.
Dr Livingston now has money from the Alzheimer’s Society to train more programme leaders.
Dr Doug Brown, of the Alzheimer’s Society, said: “If results like these were found with a new drug, it would be hailed a breakthrough.”
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.